Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS

Slides:



Advertisements
Similar presentations
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
Advertisements

High-density lipoprotein subclasses in subjects with impaired fasting glucose Filippatos TD 1, Barkas F 1, Klouras E 1, Liontos A 1, Rizos EC 1, Gazi I.
Lipoprotein Structure, Function, and Metabolism
ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
Lipid Disorders and Management in Diabetes
More Facts on Fats Lipids and Health.
Friend or Foe? High HDL Cholesterol. High Density Lipoprotein Origin: liver Content: 18-25% TC content 45-55% Protein 2-7% TG 20-30% Phospholipids Density:
Lesson 1 What is Coronary Artery Disease? Coronary Artery Disease also known as Coronary Heart Disease.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Global impact of ischemic heart disease World Heart Federation, 2011.
Lipoproteins/Particles
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
20 Cardiovascular Disease and Physical Activity chapter.
METABOLIC Syndrome: a Global Perspective
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Focus On OBESITY, METABOLISM, AND DISEASE RISK. Obesity and Disease Risk Copyright 2012, John Wiley & Sons Canada, Ltd.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Cholesterol. What is cholesterol? Waxy, fat-like substance found in all cells. Dietary cholesterol – found only in animal-based foods Blood cholesterol.
Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.
1 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Diabetes Care 28:1547–1554,
Lab (6): Lipids profile KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012 T.A Nouf Alshareef
The presence of cardiovascular disease is an important predictor of mortality in patients with end-stage renal disease, as it accounts for almost 50 percent.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
YOUR HEALTH SCREENING RESULTS
Lipids profile.
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,
Note Final Exam-please check final schedule.
Triglyceride determination
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Adiponectin Correlation With Plasma Lipoprotein Subclasses Determined By NMR And With The Risk Of Venous Thrombosis. Fernández JA, Deguchi H, Pecheniuk.
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
HYPERLIPIDEMIAS The Basics.
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
Elevated Circulating Levels of Inflammatory Markers in
TOTAL CHOLESTEROL.
New Risk Factors for Heart Disease
Serum Cholesterol Presented By Assist.Lecturer Aseel Ghassan Daoud
Obesity Dr. Sumbul Fatma.
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Atherosclerosis, Plaque Imaging
HDL cholesterol and cardiovascular risk Epidemiological evidence
First time a CETP inhibitor shows reduction of serious CV events
HDL cholesterol and cardiovascular risk
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
FATS- Familial Atherosclerosis Treatment Study
The ASSERT Study.
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
Note Final Exam-please check final schedule.
Comparison of lipid profile and glycosylated hemoglobin levels among HIV-infected and non-HIV-infected individuals in Lesotho: a community-based cross-sectional.
Baseline characteristics of HPS participants by prior diabetes
The results of the SHARP trial
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Type 2 diabetes: Overlap of clinical conditions
Note Final Exam-please check final schedule
بسم الله الرحمن الرحيم.
Lipid profile test 52 By Dr. Sakar Karem Abdulla
Note Final Exam-please check final schedule.
To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?  Carl J. Lavie, MD, Richard V. Milani, MD, James.
Note Final Exam-please check final schedule.
Lipoprotein Metabolism
The results of the SHARP trial
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS Correlation of Small dense LDL cholesterol and Apolipoprotein B with LDL Cholesterol and its Clinical significance in Overweight, Type 2 Diabetes Mellitus and Coronary Artery Disease Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS

Specific objectives Introduction to sdLDL and Apo B Why is Triglycerides/HDL ratio important Why particle numbers of LDL are important Association of sdLDL and Apo B with severity of CAD, DM and obesity Correlation of sdLDL with LDL cholesterol

Introduction Coronary Artery Disease on rise Disorders of lipid metabolism leading cause Diabetes and obesity Central obesity

Intro… increased triglyceride and HDL levels increased triglyceride content of LDL and HDL glycation of apolipoprotein increased susceptibility of LDL to oxidation

Small dense LDL more atherogenic they are taken up more easily by arterial wall readily oxidized and not easily cleared from plasma

Apolipoprotein B Every LDL particle contain an Apo B molecule Apo B levels within the LDL sub fraction provide a direct measure of LDL particle number in the circulation more closely associated than non HDL cholesterol with central obesity, insulin resistance and inflammation

Standard Lipid Profile Total Cholesterol LDLc HDLc Triglycerides Non-HDL

Why not to rely on LDL People with obesity, metabolic syndrome or diabetes have TG HDLc normal or near normal LDLc VLDLc IDL Increased risk of atherosclerosis

TG/HDL Ratio > 4 , powerful independent indicator of CAD Ideal (<2) >6 is much too high Increased ratio indicates that particles are small Small particles carries less cholesterol than a large particle

Phenotypes Pattern A: TG, Large buoyant LDL, particle size >25.5nm Pattern B: TG, Small dense LDL, particle size <25 nm

AIM To estimate small dense LDL cholesterol and Apolipoprotein B in serum and to determine their clinical significance in obese, type 2 diabetic and CAD cases.

Materials and methods 100 known cases each of CAD, type 2 diabetes, overweight and 100 age and sex matched healthy controls. BMI>25 kg/m2 were considered overweight. CAD as >50% stenosis of one or more branches of the coronary arteries

Exclusion Criteria Cases with acute and chronic liver and kidney disease Cases with clinically overt autoimmune disease like SLE, Rheumatoid Arthritis Cases with acute infections Hypo or hyperthyroidism Type 1 diabetes Patients on statin therapy

Inclusion criteria for controls non hypertensive normal OGTT normal resting 12 lead ECG absence of history of angina or myocardial infarction no risk factors for CAD

Severity of CAD n=25 (62.5%) cases with triple vessel disease (TVD) had sdLDL>50 mg/dL. n=20 (50%) cases with TVD and n=11 (46%) cases with DVD had Apo B >100 mg/dL.

Correlation of sdLDL and Apo B with LDL

sdLDL and CAD cases

Apo B and CAD cases

sdLDL and Diabetics

Discussion TG: DM> CAD> Overweight > Controls HDL: Overweight> Control> DM > CAD Apo B: Diabetic>CAD>Overweight>Control sdLDL: Diabetic>CAD>Overweight>Control TG:HDL: Diabetic (7.07)> CAD (4.29)> Overweight (3.57)> Overweight (3.01)

Discussion M Krauss et al. (40-50%)of CAD patients with small dense LDL phenotype have 2- to 3-fold increase in disease risk. sdLDL is associated with serum triglyceride level because TG moves from VLDL to LDL and HDL in exchange for cholestryl ester and is ultimately removed from these particles rendering them smaller Witztum et al.

Discussion A larger number of smaller particles is needed to carry a certain amount of cholesterol than if they are larger LDL particle number, in addition to composition, may be important in cases with CAD Tornvall et al.

Conclusion Present obesity phenotype includes higher percentage of body fat with higher truncal and abdominal fat at a lower lean body mass which has more tendency for atherogenic particles like Apo B and sdLDL. Prevention and treatment of IHD should be focused on reducing the number of atherogenic particles besides the particle composition Tornvall et al.

Take Home Message Importance of triglycerides in lipid profile test Importance of particle number along with particle composition Phenotypes of LDL